Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment

References

• Ayame H, Morimoto N, Akiyoshi K. 2008. Self-assembled cationic nanogels for intracellular protein delivery. Bioconjugate Chem. 19:882–890.
   PubMed Web of Science ®Google Scholar
• Bajaj A, Mishra SK, Kondaiah P, Bhattacharya S. 2008. Effect of the headgroup variation on the gene transfer properties of cholesterol based cationic lipids possessing ether linkage. Biochim Biophys Acta. 1778:1222–1236.
   PubMed Web of Science ®Google Scholar
• Barichello JM, Ishida T, Kiwada H. 2010. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation. Methods Mol Biol. 605:461–472.
   PubMedGoogle Scholar
• Barr FA, Silljé HHW, Nigg EA. 2004. Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol. 5:429.
   PubMed Web of Science ®Google Scholar
• Benson JR, Jatoi I. 2012. The global breast cancer burden. Future Oncol. 8:697–702.
   PubMed Web of Science ®Google Scholar
• Boger DL, Fink BE, Brunette SR, Tse WC, Hedrick MP. 2001. A simple, high-resolution method for establishing DNA binding affinity and sequence selectivity. J Am Chem Soc. 123:5878–5891.
   PubMed Web of Science ®Google Scholar
• Böhm G, Muhr R, Jaenicke R. 1992. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng Des Sel. 5:191–195.
   Web of Science ®Google Scholar
• Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA, Corey DR. 2003. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry. 42:7967–7975.
   PubMed Web of Science ®Google Scholar
• Bulbake U, Doppalapudi S, Kommineni N, Khan W. 2017. Liposomal formulations in clinical use: an updated review. Pharmaceutics. 9:12.
   PubMed Web of Science ®Google Scholar
• Bulbake U, Kommineni N, Bryszewska M, Ionov M, Khan W. 2018. Cationic liposomes for co-delivery of paclitaxel and anti-Plk1 siRNA to achieve enhanced efficacy in breast cancer. J Drug Deliv Sci Technol. 48:253–265.
   Web of Science ®Google Scholar
• DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. 2016. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 66:31–42.
   PubMed Web of Science ®Google Scholar
• Dzmitruk V, Szulc A, Shcharbin D, Janaszewska A, Shcharbina N, Lazniewska J, Novopashina D, Buyanova M, Ionov M, Klajnert-Maculewicz B, et al. 2015. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (B). Efficiency of pharmacological action. Int J Pharm. 485:288–294.
   PubMed Web of Science ®Google Scholar
• Geusens B, Lambert J, De Smedt SC, Buyens K, Sanders NN, Van Gele M. 2009. Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes. J Control Release. 133:214–220.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn H-J. 2003. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol. 21:3357–3365.
   PubMed Web of Science ®Google Scholar
• Gray DM, Liu J-J, Ratliff RL, Allen FS. 1981. Sequence dependence of the circular dichroism of synthetic double‐stranded RNAs. Biopolymers. 20:1337–1382.
   Web of Science ®Google Scholar
• Ionov M, Lazniewska J, Dzmitruk V, Halets I, Loznikova S, Novopashina D, Apartsin E, Krasheninina O, Venyaminova A, Milowska K, et al. 2015. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction. Int J Pharm. 485:261–269.
   PubMed Web of Science ®Google Scholar
• Itaka K, Kataoka K. 2009. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms. Eur J Pharm Biopharm. 71:475–483.
   PubMed Web of Science ®Google Scholar
• Kang H, DeLong R, Fisher MH, Juliano RL. 2005. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm Res. 22:2099–2106.
   PubMed Web of Science ®Google Scholar
• Katas H, Alpar HO. 2006. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 115:216–225.
   PubMed Web of Science ®Google Scholar
• Kim DH, Rossi JJ. 2007. Strategies for silencing human disease using RNA interference. Nat Rev Genet. 8:173.
   PubMed Web of Science ®Google Scholar
• Kim H-K, Davaa E, Myung C-S, Park J-S. 2010a. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Int J Pharm. 392:141–147.
   PubMed Web of Science ®Google Scholar
• Kim S-A, Kwon SM, Yoon JH, Ahn SG. 2010b. The antitumor effect of PLK1 and HSF1 double knockdown on human oral carcinoma cells. Int J Oncol. 36:867–872.
   PubMed Web of Science ®Google Scholar
• Kumar MNVR, Sameti M, Mohapatra SS, Kong X, Lockey RF, Bakowsky U, Lindenblatt G, Schmidt CH, Lehr C-M. 2004. Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. J Nanosci Nanotech. 4:876–881.
   PubMed Web of Science ®Google Scholar
• Law M, Jafari M, Chen P. 2008. Physicochemical characterization of siRNA‐peptide complexes. Biotechnol Progress. 24:957–963.
   PubMed Web of Science ®Google Scholar
• Liu X, Erikson RL. 2003. Polo-like kinase (Plk) 1 depletion induces apoptosis in cancer cells. Proc Nat Acad Sci. 100:5789–5794.
   PubMed Web of Science ®Google Scholar
• Loup C, Zanta M-A, Caminade A-M, Majoral J-P, Meunier B. 1999. Preparation of water‐soluble cationic phosphorus‐containing dendrimers as DNA transfecting agents. Chem Eur J. 5:3644–3650.
   Web of Science ®Google Scholar
• Luo Y, Ling Y, Guo W, Pang J, Liu W, Fang Y, Wen X, Wei K, Gao X. 2010. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells. J Control Release. 147:278–288.
   PubMed Web of Science ®Google Scholar
• Ma Z, Li J, He F, Wilson A, Pitt B, Li S. 2005. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun. 330:755–759.
   PubMed Web of Science ®Google Scholar
• Mao S, Neu M, Germershaus O, Merkel O, Sitterberg J, Bakowsky U, Kissel T. 2006. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Bioconjug Chem. 17:1209–1218.
   PubMed Web of Science ®Google Scholar
• Meryet-Figuières M, Resina S, Lavigne C, Barlovatz-Meimon G, Lebleu B, Thierry AR. 2007. Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range. Biochimie. 89:1228–1233.
   PubMed Web of Science ®Google Scholar
• Naldini L. 2015. Gene therapy returns to centre stage. Nature. 526:351.
   PubMed Web of Science ®Google Scholar
• Nanjwade BK, Bechra HM, Derkar GK, Manvi FV, Nanjwade VK. 2009. Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharm Sci. 38:185–196.
   PubMed Web of Science ®Google Scholar
• Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F, et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
   PubMed Web of Science ®Google Scholar
• Olmsted J III, Kearns DR. 1977. Mechanism of ethidium bromide fluorescence enhancement on binding to nucleic acids. Biochemistry. 16:3647–3654.
   PubMed Web of Science ®Google Scholar
• Pandi P, Jain A, Kommineni N, Ionov M, Bryszewska M, Khan W. 2018. Dendrimer as a new potential carrier for topical delivery of siRNA: a comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA. Int J Pharm. 550:240–250.
   PubMed Web of Science ®Google Scholar
• Perrie Y, Gregoriadis G. 2000. Liposome-entrapped plasmid DNA: characterisation studies. Biochim Biophys ActaGeneral Subjects. 1475:125–132.
   PubMed Web of Science ®Google Scholar
• Poeck H, Besch R, Maihoefer C, Renn M, Tormo D, Morskaya SS, Kirschnek S, Gaffal E, Landsberg J, Hellmuth J, et al. 2008. 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nature Medicine. 14:1256.
   PubMed Web of Science ®Google Scholar
• Santhakumaran LM, Thomas T, Thomas TJ. 2004. Enhanced cellular uptake of a triplex‐forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers. Nucleic Acids Res. 32:2102–2112.
   PubMed Web of Science ®Google Scholar
• Spa¨nkuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. 2002. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Nat Cancer Instit. 94:1863–1877.
   PubMed Web of Science ®Google Scholar
• Srinivasan C, Burgess DJ. 2009. Optimization and characterization of anionic lipoplexes for gene delivery. J Control Release. 136:62–70.
   PubMed Web of Science ®Google Scholar
• Strebhardt K, Ullrich A. 2006. Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer. 6:321.
   PubMed Web of Science ®Google Scholar
• Whitehead KA, Langer R, Anderson DG. 2009. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 8:129.
   PubMed Web of Science ®Google Scholar
• Win KY, Feng S-S. 2005. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 26:2713–2722.
   PubMed Web of Science ®Google Scholar
• Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG. 2014. Non-viral vectors for gene-based therapy. Nat Rev Genet. 15:541.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li H, Sun J, Gao J, Liu W, Li B, Guo Y, Chen J. 2010. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Int J Pharm. 390:198–207.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang G, Kong C. 2013. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder. Urol Oncol. 31:1222–1230.
   PubMed Web of Science ®Google Scholar